Testing of inhaled drugs

March 01, 2010   admin   No comments

Copley Scientific has launched the world’s first commercially available apparatus designed specifically for dissolution testing of inhaled drug formulations. Based on a concept developed by Professor Jason McConville and his team at the College of Pharmacy, University of Texas, a new NGI dissolution cup and membrane holder enables dissolution testing of size-fractionated particles selected from the emitted dose. Simple to use and employing analytical methodology based on established
pharmacopoeial techniques for transdermal patches, it provides information that allows developers to more closely tailor inhaled drug
delivery. The launch underlines Copley Scientific’s commitment to commercialising
new analytical techniques for inhaled product testing and to providing the very best tools for development and QC.

  • Polls

    Should medical research that has potential use for terrorists be censored?

    View Results

    Loading ... Loading ...